{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:49:54Z","timestamp":1782485394930,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaapos.2026.104848","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:27:39Z","timestamp":1777580859000},"page":"104848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world outcomes of retinopathy of prematurity treated with primary laser versus primary anti\u2013vascular endothelial growth factor and deferred laser"],"prefix":"10.1016","volume":"30","author":[{"given":"Melissa","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Altamirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoyek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Chaaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"De Bruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iason S.","family":"Mantagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efren","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"VanderVeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-6104","authenticated-orcid":false,"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0677-7414","authenticated-orcid":false,"given":"Ryan","family":"Gise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2026.104848_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3345\/cep.2021.00773","article-title":"Retinopathy of prematurity: a review of epidemiology and current treatment strategies","volume":"65","author":"Hong","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/j.jaapos.2026.104848_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/23258160-20170630-06","article-title":"The epidemiology of retinopathy of prematurity in the United States","volume":"48","author":"Ludwig","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib3","first-page":"233","article-title":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jaapos.2026.104848_bib4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ophtha.2018.12.012","article-title":"Laser treatment for retinopathy of prematurity: a decade since ETROP","volume":"126","author":"Emami","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/bjo.2005.068304","article-title":"Long term functional and structural outcomes of laser therapy for retinopathy of prematurity","volume":"90","author":"McLoone","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaapos.2026.104848_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8383","article-title":"Intravitreal aflibercept vs laser therapy for retinopathy of prematurity: two-year efficacy and safety outcomes in the nonrandomized controlled trial FIREFLEYE next","volume":"7","author":"Stahl","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jaapos.2026.104848_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaapos.2026.104848_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013344","article-title":"Anaesthesia modalities during laser photocoagulation for retinopathy of prematurity: a retrospective, longitudinal study","volume":"7","author":"Jiang","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaapos.2026.104848_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcjo.2018.03.005","article-title":"Posterior zone I retinopathy of prematurity: spectrum of disease and outcome after laser treatment","volume":"54","author":"Katoch","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/IAE.0000000000004067","article-title":"Outcome of eyes treated for retinopathy of prematurity in posterior zone i: an Eastern India study","volume":"44","author":"Padhi","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2012.07.012","article-title":"Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation","volume":"155","author":"Sanghi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib14","first-page":"56","article-title":"Management of retinopathy of prematurity\u2014use of anti-VEGF therapy","volume":"7","author":"Tran","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jaapos.2026.104848_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaapos.2026.104848_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ophtha.2022.11.012","article-title":"Comparison in retreatments between bevacizumab and ranibizumab intravitreal injections for retinopathy of prematurity: a multicenter study","volume":"130","author":"Patel","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib18","first-page":"365","article-title":"Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone","volume":"101","author":"Mueller","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/IAE.0000000000001126","article-title":"Retinal vascular development with 0.312 mg intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: a longitudinal fluorescein angiographic study","volume":"37","author":"Lorenz","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3928\/23258160-20160229-12","article-title":"Very late reactivation of retinopathy of prematurity after monotherapy with intravitreal bevacizumab","volume":"47","author":"Snyder","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib21","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00417-025-06820-x","article-title":"Persistent avascular retina in retinopathy of prematurity","volume":"263","author":"Tan","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib22","doi-asserted-by":"crossref","first-page":"88.e1","DOI":"10.1016\/j.jaapos.2018.10.013","article-title":"Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP","volume":"23","author":"Anand","year":"2019","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104848_bib23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/IAE.0000000000001581","article-title":"Prophylactic peripheral laser and fluorescein angiography after bevacizumab for retinopathy of prematurity","volume":"38","author":"Garcia Gonzalez","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2022.07.009","article-title":"Practice patterns and outcomes of intravitreal anti-VEGF injection for retinopathy of prematurity: an international multicenter study","volume":"129","author":"Patel","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","article-title":"Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings","volume":"125","author":"Lepore","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ophtha.2016.06.055","article-title":"Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity","volume":"123","author":"Toy","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaapos.2021.02.004","article-title":"Very late-onset reactivation of retinopathy of prematurity post anti-VEGF bevacizumab treatment for type 1 ROP: a case report","volume":"25","author":"Taylor","year":"2021","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104848_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3928\/23258160-20170301-10","article-title":"Reactivation of retinopathy of prematurity three years after treatment with bevacizumab","volume":"48","author":"Hajrasouliha","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaapos.2013.01.004","article-title":"Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab","volume":"17","author":"Ittiara","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104848_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3928\/23258160-20180803-11","article-title":"Late ROP reactivation and retinal detachment in a teenager","volume":"49","author":"Golas","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib31","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaapos.2026.104848_bib32","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/IAE.0000000000002663","article-title":"Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti-vascular endothelial growth factor monotherapy","volume":"40","author":"Ling","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2026.104848_bib33","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaapos.2026.104848_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamaophthalmol.2022.3988","article-title":"The male to female ratio in treatment-warranted retinopathy of prematurity: a systematic review and meta-analysis","volume":"140","author":"Hoyek","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaapos.2021.02.002","article-title":"Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity","volume":"25","author":"Hong","year":"2021","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaapos.2026.104848_bib36","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/j.1538-9235.1997.tb04831.x","article-title":"Infant emmetropization: longitudinal changes in refraction components from nine to twenty months of age","volume":"74","author":"Ehrlich","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jaapos.2026.104848_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.63.5.339","article-title":"Changes in refraction between the ages of 1 and 3 1\/2 years","volume":"63","author":"Ingram","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/bjo.67.3.170","article-title":"Myopia in premature babies with and without retinopathy of prematurity","volume":"67","author":"Nissenkorn","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bjo.2005.083535","article-title":"Change of refractive state and eye size in children of birth weight less than 1701 g","volume":"90","author":"O\u2019Connor","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40942-023-00456-x","article-title":"Investigating the factors affecting myopia in retinopathy of prematurity after laser treatment","volume":"9","author":"Asano","year":"2023","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.jaapos.2026.104848_bib42","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1038\/s41433-020-01321-z","article-title":"Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity","volume":"35","author":"Mori","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.jaapos.2026.104848_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2021.11.015","article-title":"Real-world visual outcomes of laser and anti-VEGF treatments for retinopathy of prematurity","volume":"238","author":"Gundlach","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaapos.2026.104848_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/APO.0000000000000302","article-title":"Update on anti-vascular endothelial growth factor safety for retinopathy of prematurity","volume":"9","author":"Enr\u00edquez","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jaapos.2026.104848_bib45","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol Ther"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853126001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:22:43Z","timestamp":1782483763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853126001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1091853126001217"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.104848","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world outcomes of retinopathy of prematurity treated with primary laser versus primary anti\u2013vascular endothelial growth factor and deferred laser","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2026.104848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Association for Pediatric Ophthalmology and Strabismus.","name":"copyright","label":"Copyright"}],"article-number":"104848"}}